Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

Last week, the markets wrapped up a shortened trading week (due to Good Friday) with widespread losses, as investors grappled with trade ...

The major indexes fell in the holiday-shortened week after hitting resistance. It's still a market correction. Netflix ...

If approved, the pill is expected to be far easier to administer than current injectables — and far easier to manufacture.

Eli Lilly is getting closer to bringing a weight loss pill to market, but CEO David Ricks notes certain factors need to be considered to prevent prices from ballooning.

Most U.S. stocks climbed Thursday, but the worst drop for UnitedHealth Group in a quarter of a century kept Wall Street in ...

The UnitedHealth slide weighed heavily on the Dow, which fell 527 points, or 1.3%.

The Dow Jones Industrial Average is tumbling by another 440 points in midday trading today, as President Trump criticized ...

The major U.S. equities indexes were mixed at midday Thursday, with the Dow Jones Industrial Average down close to 400 points ...

Eli Lilly and Company (LLY) is currently at $852.76, up $117.87 or 16.04% --Would be highest close since March 24, 2025, when it closed at $864.90 --On pace for largest percent increase since June 29, ...